A preliminary evaluation of the psychometric profiles in Chinese men with chronic prostatitis/chronic pelvic pain syndrome

被引:15
|
作者
Zhang Guo-xi [1 ]
Bai Wen-jun [1 ]
Xu Tao [1 ]
Wang Xiao-feng [1 ]
机构
[1] Peking Univ, Dept Urol, Peoples Hosp, Beijing 100044, Peoples R China
关键词
chronic prostatitis/chronic pelvic pain syndrome; hospital anxiety and depression scale; psychological disorders; HOSPITAL ANXIETY; LATER LIFE; DEPRESSION SCALE; PREVALENCE; DISORDERS; SYMPTOMS; STRESS; VALIDATION; VALIDITY; SEARCH;
D O I
10.3760/cma.j.issn.0366-6999.2011.04.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background As one of the most commonly diagnosed diseases, chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is characterized by a variety of complex symptoms. Anxiety and depression are two of the most prevalent clinical manifestations of patients with CP/CPPS, and have adverse effects on the health of the subjects and prognosis of comorbidities. Such psychological disorders, however, have not been deeply and thoroughly studied in China. The aim of this study was to investigate the prevalence and severity of psychological disorders in Chinese adults with CP/CPPS. Methods From April 2008 to June 2009, 80 patients and 40 age-matched healthy men participating in a voluntary health examination were recruited. The majority of the subjects completed the questionnaires on the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) as well as the hospital anxiety and depression scale (HADS). Results Of all the participants, 77 (96.3%) patients and 37 (92.5%) healthy controls completed the questionnaires. The average NIH-CPSI total score was 21.0 +/- 9.5 for the patients and 2.2 +/- 1.5 for the controls (P=0.03). Of the 77 patients with CP/CPPS, 48 (62.3%), 5 (6.5%), and 1 (1.2%) had anxiety symptoms, depression symptoms, or both anxiety and depression symptoms, respectively. For the controls, the average HADS anxiety and depression scores in patients were 14.5 +/- 6.8 and 5.2 +/- 4.5, which were both significantly higher than in controls. Moreover, the prevalence and the symptom scores of both the HADS anxiety and depression were higher for the younger age group (< 35 years) than for the older age group (< 35 years). Conclusions This preliminary study revealed that male patients with CP/CPPS had a higher prevalence of psychological disorders than in the control subjects. Moreover, the differences of the prevalence and severity of the psychological symptoms between the two different age groups may imply that psychological disorders related to CP/CPPS may be relieved with increasing age. The present study indicated that psychological evaluation is important in men with CP/CPPS, especially in younger men. Chin Med J 2011;124(4):514-518
引用
收藏
页码:514 / 518
页数:5
相关论文
共 50 条
  • [41] National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) Symptom Evaluation in Multinational Cohorts of Patients with Chronic Prostatitis/Chronic Pelvic Pain Syndrome
    Wagenlehner, Florian M. E.
    van Till, J. W. Olivier
    Magri, Vittorio
    Perletti, Gianpaolo
    Houbiers, Jos G. A.
    Weidner, Wolfgang
    Nickel, J. Curtis
    EUROPEAN UROLOGY, 2013, 63 (05) : 953 - 959
  • [42] Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome: a Cochrane systematic review
    Franco, Juan V. A.
    Turk, Tarek
    Jung, Jae Hung
    Xiao, Yu-Tian
    Iakhno, Stanislav
    Ignacio Tirapegui, Federico
    Garrote, Virginia
    Vietto, Valeria
    BJU INTERNATIONAL, 2020, 125 (04) : 490 - 496
  • [43] Psychological factors and pain catastrophizing in men with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS): a meta-analysis
    Huang, Xinfei
    Qin, Zhan
    Cui, Hongliang
    Chen, Jianhuai
    Liu, Tao
    Zhu, Yongkang
    Yuan, Shaoying
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2020, 9 (02) : 485 - 493
  • [44] The Challenge of Erectile Dysfunction in the Man with Chronic Prostatitis/Chronic Pelvic Pain Syndrome
    Shoskes, Daniel A.
    CURRENT UROLOGY REPORTS, 2012, 13 (04) : 263 - 267
  • [45] Re: Alfuzosin and Symptoms of Chronic Prostatitis-Chronic Pelvic Pain Syndrome
    Madersbacher, Stephan
    EUROPEAN UROLOGY, 2009, 56 (02) : 399 - 399
  • [46] Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome
    Xia Dan
    Wang Ping
    Chen Jun
    Wang Shuo
    Jiang Hai
    CHINESE MEDICAL JOURNAL, 2011, 124 (14) : 2158 - 2161
  • [47] Acupuncture for chronic prostatitis/chronic pelvic pain syndrome: study protocol for a randomized controlled trial
    Qin, Zongshi
    Liu, Yan
    Zhou, Kehua
    Wu, Jiani
    Pang, Ran
    Li, Ning
    Xu, Chang
    Kwong, Joey S. W.
    Liu, Zhishun
    TRIALS, 2017, 18
  • [48] Psychosocial mechanisms of the pain and quality of life relationship for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS)
    Krsmanovic, Adrijana
    Tripp, Dean A.
    Nickel, J. Curtis
    Shoskes, Daniel A.
    Pontari, Michel
    Litwin, Mark S.
    McNaughton-Collins, Mary F.
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2014, 8 (11-12): : 403 - 408
  • [49] Brain Functional and Anatomical Changes in Chronic Prostatitis/Chronic Pelvic Pain Syndrome
    Farmer, Melissa A.
    Chanda, Mona L.
    Parks, Elle L.
    Baliki, Marwan N.
    Apkarian, A. Vania
    Schaeffer, Anthony J.
    JOURNAL OF UROLOGY, 2011, 186 (01) : 117 - 124
  • [50] Chronic Prostatitis and Pelvic Pain Syndrome: Another Autoimmune Disease?
    Lei Chen
    Meng Zhang
    Chaozhao Liang
    Archivum Immunologiae et Therapiae Experimentalis, 2021, 69